Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplantJohn J. Friedewald, Michaël Abécassis, Brian Armstrong et al.|American Journal of Transplantation|2018Cited by 156
Molecular Classifiers for Acute Kidney Transplant Rejection in Peripheral Blood by Whole Genome Gene Expression ProfilingSunil M. Kurian, Daniel R. Salomon, Alun Williams et al.|American Journal of Transplantation|2014Cited by 114
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal FunctionChristopher L. Marsh, M. Roy First, Sunil M. Kurian et al.|Transplantation Proceedings|2019Cited by 39
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and PlatformSunil M. Kurian, Daniel R. Salomon, Eric J. Velazquez et al.|American Journal of Transplantation|2017Cited by 38
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression SignatureJosh Levitsky, Michaël Abécassis, Manoj Kandpal et al.|Transplantation|2021Cited by 34